Diagnostic Testing for Productive Cough and Fever
For an adult outpatient with productive cough and fever, measure C-reactive protein (CRP) and obtain a chest X-ray if vital signs are abnormal; routine microbiological testing is not needed.
Clinical Assessment First
Begin by evaluating for pneumonia-suggestive features 1:
- Key symptoms: dyspnea, pleural pain, sweating/fevers/shivers, temperature ≥38°C
- Key signs: tachypnea, crackles, diminished breath sounds, tachycardia
- Absence of runny nose increases pneumonia likelihood
Diagnostic Testing Algorithm
1. C-Reactive Protein (CRP) - Recommended
Measure CRP to strengthen both diagnosis and exclusion of pneumonia 1:
- CRP ≥30 mg/L + suggestive symptoms/signs → high likelihood of pneumonia
- CRP <10 mg/L → pneumonia unlikely, can rule out
- CRP 10-50 mg/L without dyspnea and daily fever → pneumonia unlikely
- CRP 10-50 mg/L with dyspnea or daily fever → consider pneumonia
This biomarker significantly reduces diagnostic uncertainty and can decrease unnecessary antibiotic prescriptions by 9.1% 2.
2. Chest Radiography - Conditional
Order chest X-ray if abnormal vital signs are present (Grade 2C) 1:
- Abnormal vital signs include: fever ≥38°C, tachypnea, tachycardia, hypoxia
- Chest X-ray improves diagnostic accuracy and identifies:
- Multilobar involvement (severity marker)
- Complications (pleural effusion, lung abscess)
- Alternative diagnoses (bronchial obstruction, tuberculosis)
If chest X-ray unavailable and pneumonia suspected: use empiric antibiotics per local guidelines 1.
3. Procalcitonin - NOT Recommended
Do not routinely measure procalcitonin 1. No added benefit over CRP in the outpatient setting.
4. Microbiological Testing - NOT Routine
Routine sputum cultures, blood cultures, or respiratory pathogen panels are not needed 1, 3.
Exception: Consider microbiological testing only if results would change therapy, such as:
- Treatment failure on initial antibiotics
- Suspected resistant organisms
- Immunocompromised patients
- Severe illness requiring ICU admission
5. Influenza Testing - If Suspected
If influenza is suspected clinically, initiate antiviral treatment within 48 hours without waiting for test results 1. Early antivirals may decrease antibiotic use, hospitalization, and improve outcomes.
Key Clinical Pitfalls
Avoid over-testing: The 2019 CHEST guidelines explicitly recommend against routine microbiological workup in outpatients because even extensive testing fails to identify a pathogen in >50% of cases 1, 3, 4.
Don't skip CRP: This simple point-of-care test is your most valuable tool for reducing diagnostic uncertainty and preventing unnecessary antibiotics 2, 5.
Normal vital signs + normal lung exam: If both are normal, do not prescribe antibiotics routinely regardless of cough and fever 1.
Evidence Quality Note
These recommendations come from the 2019 American College of Chest Physicians (CHEST) guidelines 1, which provide the most current evidence-based approach. The CRP recommendation is Grade 2C (weak recommendation, low-quality evidence), but represents expert consensus that the benefits of reduced antibiotic overuse outweigh the minimal risks and costs of testing.